6505--Buprenorphine Pre-solicitation notice
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79726R0004
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Amber Zavala amber.zavala@va.gov (708) 786-5245
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center is procuring Buprenorphine HCL/Naloxone HCL Tablets for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through an unrestricted competitive procurement. Offerors must provide the exact drug name as it appears on the label and supply a unique NDC number; glass bottles are not acceptable. The contract will be awarded to a single responsible offeror capable of providing an uninterrupted supply source, with distribution occurring through the VA's and DOD's Pharmaceutical Prime Vendor Programs. The solicitation, numbered 36E79726R0004, will be issued electronically in commercial item format in accordance with FAR Part 12 on or about January 5, 2026, with a tentative closing date of January 19, 2026. Interested parties should direct questions to Amber Zavala at amber.zavala@va.gov and continuously monitor SAM.gov for updates and amendments.
This procurement carries no set-aside designations and represents an unrestricted opportunity for all responsible sources. The contract will be structured for a one-year base period plus four pre-priced one-year option periods, establishing a potential five-year relationship. The estimated annual requirements total 171,239 bottles of Buprenorphine HCL 2mg/Naloxone HCL 0.5mg sublingual tablets (30-count) and 251,144 bottles of Buprenorphine HCL 8mg/Naloxone HCL 2mg sublingual tablets (30-count), representing a combined annual volume of approximately 422,383 bottles. While specific budget information is not disclosed in the pre-solicitation notice, the volume of estimated annual requirements suggests substantial contract value. All documentation will be available electronically at SAM.gov, with no paper copies provided upon request.
Notice text
Page 2 of 2
Page 2 of 2
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0004 for an unrestricted procurement for Buprenorphine HCL/Nalaxone HCL Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation # 36E79726R0004 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 01/05/2026 with a tentative closing date of 01/19/2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov.
The estimated annual requirements are as follows:
Description Size Estimated Annual Requirements (Bottle)
BuprenorphineHCL 2mg/Naloxone HCL 0.5mg Tab, Sublingual 30 171,239
BuprenorphineHCL 8mg/Naloxone HCL 2mg Tab, Sublingual 30 251,144
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79726R0004_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Buprenorphine Award | Award Notice | |
| 6505--Buprenorphine Pre-solicitation notice | Solicitation | |
| 6505--Buprenorphine Pre-solicitation notice | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity